FDA Adverse Event Injury Summary report: N

PROXIMA HI OFFSET L SZ 4

MDR report key: 5027172 · Received August 25, 2015

Report

Report Number
1818910-2015-28872
Event Type
Injury
Date Received
August 25, 2015
Date of Event
November 27, 2012
Report Date
August 21, 2015
Manufacturer
DEPUY INTL., LTD. - 8010379
Product Code
KWA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. NO 510(K) NUMBER PROVIDED BECAUSE THIS IMPLANT IS SOLD INTERNATIONALLY WITH DIFFERENT INDICATIONS FOR USE; IT IS CURRENTLY SOLD IN THE US UNDER A DIFFERENT PART NUMBER. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY. THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. WWCAPA (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

ASR REVISION. ASR XL - LEFT. REASON(S) FOR REVISION: PAIN. UPDATE: RECEIVED 12TH FEBRUARY, 2014. TAPER SLEEVE AND STEM ADDED. LOT NUMBER NOT AVAILABLE FOR STEM. NEW BOXES COMPLETED. UPDATE: ATTACHED LEGAL DOCUMENT, ADDED ADDITIONAL REASONS FOR REVISION: PAIN, HIGH METAL ION LEVELS, ALLERGIC REACTION, METALLOSIS, AND DIFFICULTY IN MOVEMENT. MARKED LEGAL, ADDED PATIENTS NAME AND GENDER, ADDED ALL EXPIRY DATES, ALL MANUFACTURING DATES. TAKEN FROM LEGAL LETTER DATED 21ST AUGUST 2015.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
562270 PROXIMA HI OFFSET L SZ 4 HIP FEMORAL STEM/SLEEVE KWA DEPUY INTL., LTD. - 8010379 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention